X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (14814) 14814
Newsletter (1731) 1731
Publication (1130) 1130
Book Review (228) 228
Book Chapter (51) 51
Magazine Article (47) 47
Dissertation (44) 44
Newspaper Article (30) 30
Conference Proceeding (13) 13
Book / eBook (11) 11
Trade Publication Article (8) 8
Reference (7) 7
Paper (2) 2
Web Resource (2) 2
Data Set (1) 1
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
fluoxetine (12039) 12039
humans (7493) 7493
male (6741) 6741
psychiatry (5653) 5653
female (5206) 5206
index medicus (4380) 4380
animals (4151) 4151
pharmacology & pharmacy (3902) 3902
adult (3705) 3705
neurosciences (3473) 3473
antidepressants (3208) 3208
depression (3051) 3051
fluoxetine - therapeutic use (3032) 3032
fluoxetine - pharmacology (2615) 2615
middle aged (2604) 2604
rats (2393) 2393
serotonin (2263) 2263
serotonin uptake inhibitors - therapeutic use (2243) 2243
treatment outcome (2232) 2232
depression, mental (2078) 2078
double-blind (1831) 1831
research (1793) 1793
depressive disorder - drug therapy (1779) 1779
clinical neurology (1730) 1730
major depression (1710) 1710
antidepressive agents - therapeutic use (1568) 1568
adolescent (1561) 1561
serotonin uptake inhibitors - pharmacology (1496) 1496
mice (1442) 1442
double-blind method (1314) 1314
aged (1304) 1304
drugs (1301) 1301
dose-response relationship, drug (1290) 1290
analysis (1276) 1276
serotonin reuptake inhibitors (1240) 1240
paroxetine (1173) 1173
drug therapy (1171) 1171
fluoxetine - adverse effects (1136) 1136
antidepressant (1123) 1123
care and treatment (1104) 1104
sertraline (1090) 1090
brain (1088) 1088
anxiety (1074) 1074
depressive disorder, major - drug therapy (1026) 1026
antidepressive agents, second-generation - therapeutic use (1025) 1025
serotonin uptake inhibitors - adverse effects (1006) 1006
psychiatric status rating scales (999) 999
fluoxetine - administration & dosage (980) 980
antidepressive agents - pharmacology (970) 970
depression - drug therapy (961) 961
serotonin uptake inhibitors (933) 933
rats, sprague-dawley (918) 918
major depressive disorder (890) 890
psychology, clinical (890) 890
time factors (873) 873
efficacy (861) 861
depressive disorder - psychology (808) 808
drug therapy, combination (807) 807
placebo (795) 795
reports (789) 789
obsessive-compulsive disorder (729) 729
disease models, animal (714) 714
child (711) 711
imipramine (690) 690
drug administration schedule (689) 689
serotonin - metabolism (689) 689
behavior, animal - drug effects (684) 684
rats, wistar (682) 682
serotonin uptake inhibitors - administration & dosage (681) 681
stress (662) 662
mental depression (661) 661
children (649) 649
article (648) 648
citalopram (648) 648
health aspects (647) 647
universities and colleges (641) 641
behavior (636) 636
fluvoxamine (627) 627
placebo-controlled trial (612) 612
antidepressive agents - adverse effects (595) 595
hippocampus (588) 588
disorder (583) 583
drug interactions (574) 574
comorbidity (572) 572
fluoxetine treatment (567) 567
medical research (546) 546
psychology (542) 542
severity of illness index (540) 540
risk factors (523) 523
behavioral sciences (498) 498
brain - drug effects (497) 497
clomipramine (496) 496
motor activity - drug effects (495) 495
medicine, general & internal (490) 490
antidepressive agents, second-generation - pharmacology (485) 485
analysis of variance (484) 484
phenols (481) 481
antidepressive agents, second-generation - adverse effects (480) 480
brain - metabolism (473) 473
venlafaxine (473) 473
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (9) 9
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
OISE - May be requested in 6-10 wks (1) 1
OISE - Theses (1) 1
Online Resources - Online (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Toronto East General Hospital - Chaplain Dept. (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (16233) 16233
German (118) 118
French (107) 107
Spanish (69) 69
Russian (39) 39
Portuguese (25) 25
Chinese (24) 24
Turkish (23) 23
Dutch (19) 19
Polish (18) 18
Japanese (12) 12
Italian (8) 8
Persian (7) 7
Norwegian (6) 6
Danish (5) 5
Hungarian (5) 5
Czech (3) 3
Korean (2) 2
Arabic (1) 1
Croatian (1) 1
Hebrew (1) 1
Icelandic (1) 1
Slovenian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American Academy of Child & Adolescent Psychiatry, ISSN 0890-8567, 12/2006, Volume 45, Issue 12, pp. 1404 - 1411
Journal Article
Journal of the American Academy of Child & Adolescent Psychiatry, ISSN 0890-8567, 2010, Volume 49, Issue 2, pp. 132 - 140
Objective The impact of childhood trauma was examined in 427 adolescents (54% girls, 74% Caucasian, mean = 14.6, SD = 1.5) with major depressive disorder... 
Pediatrics | Psychiatry | Depression | Treatment | Trauma | Adolescent | SEXUAL-ABUSE | PSYCHIATRY | PSYCHOLOGY, DEVELOPMENTAL | DISORDERS | PSYCHOTHERAPY | RELIABILITY | RANDOMIZED CONTROLLED-TRIAL | MAJOR DEPRESSION | COMBINATION | CHILDREN | MODERATORS | COGNITIVE-BEHAVIORAL THERAPY | PEDIATRICS | Outcomes of Treatment | Behavior Modification | Interaction | Sexual Abuse | Cognitive Restructuring | Classification | Adolescents | Depression (Psychology) | Rating Scales | Program Effectiveness | Depressive Disorder, Major - blood | Humans | Male | Antidepressive Agents, Second-Generation - therapeutic use | Child Abuse, Sexual - diagnosis | Stress Disorders, Post-Traumatic - therapy | Stress Disorders, Post-Traumatic - diagnosis | Female | Fluoxetine - therapeutic use | Personality Inventory - statistics & numerical data | Child | Child Abuse, Sexual - psychology | Double-Blind Method | Life Change Events | Depressive Disorder, Major - therapy | Psychometrics | Treatment Outcome | Combined Modality Therapy | Stress Disorders, Post-Traumatic - psychology | Depressive Disorder, Major - psychology | Stress Disorders, Post-Traumatic - blood | Child Abuse - psychology | Cognitive Therapy | Depressive Disorder, Major - diagnosis | Longitudinal Studies | Child Abuse - diagnosis | Psychic trauma in children | Care and treatment | Behavior therapy | Research | Fluoxetine | Depression in adolescence | Mental health care | Cognitive therapy | Child abuse & neglect | Teenagers | Mental depression
Journal Article
Journal of the American Academy of Child and Adolescent Psychiatry, ISSN 0890-8567, 2009, Volume 48, Issue 3, pp. 330 - 339
Objective: To advance knowledge regarding strategies for treating selective serotonin reuptake inhibitor (SSRI)-resistant depression in adolescents, we... 
Treatment-resistant | Depression | Cognitive-behavioral therapy | Adolescents | adolescents | PSYCHIATRY | PSYCHOLOGY, DEVELOPMENTAL | PSYCHOTHERAPY | cognitive-behavioral therapy | RELIABILITY | RANDOMIZED CONTROLLED-TRIAL | MAJOR DEPRESSION | PHARMACOTHERAPY | CHILDREN | INTERVENTIONS | CLINICAL-TRIALS | PEDIATRICS | depression | COLLABORATIVE RESEARCH-PROGRAM | SCALE | treatment-resistant | Outcomes of Treatment | Behavior Modification | Cognitive Restructuring | Drug Therapy | Predictor Variables | Psychological Patterns | Counseling Effectiveness | Depression (Psychology) | Counseling Techniques | Symptoms (Individual Disorders) | Antidepressive Agents, Second-Generation - adverse effects | Cyclohexanols - adverse effects | Prognosis | Humans | Depressive Disorder - diagnosis | Serotonin Uptake Inhibitors - therapeutic use | Serotonin Uptake Inhibitors - adverse effects | Depressive Disorder - drug therapy | Male | Combined Modality Therapy | Paroxetine - therapeutic use | Cognitive Behavioral Therapy | Antidepressive Agents, Second-Generation - therapeutic use | Paroxetine - adverse effects | Venlafaxine Hydrochloride | Personality Inventory | Adolescent | Cyclohexanols - therapeutic use | Female | Depressive Disorder - psychology | Fluoxetine - therapeutic use | Chronic Disease | Drug Resistance | Fluoxetine - adverse effects | Cognitive therapy | Serotonin agents | Patient outcomes | Depression, Mental | Adolescent medicine | Dosage and administration | Drug therapy | Teenagers | Inhibitor drugs | Mental depression | Medical treatment | Clinical outcomes | Index Medicus
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 08/2017, Volume 76, Issue 8, pp. 1327 - 1339
The aim was to update the 2009 European League against Rheumatism (EULAR) recommendations for the treatment of systemic sclerosis (SSc), with attention to new... 
Systemic Sclerosis | Cyclophosphamide | Treatment | Methotrexate | ORAL PROSTACYCLIN ANALOG | SCLERODERMA RENAL CRISIS | DIGITAL ULCERS | DOUBLE-BLIND TRIAL | PULMONARY ARTERIAL-HYPERTENSION | INTESTINAL BACTERIAL OVERGROWTH | INTRAVENOUS EPOPROSTENOL | RAYNAUDS-PHENOMENON SECONDARY | STANDARDIZED OPERATING PROCEDURES | RHEUMATOLOGY | STEM-CELL TRANSPLANTATION | Glucocorticoids - therapeutic use | Pyrazoles - therapeutic use | Humans | Gastrointestinal Diseases - etiology | Lung Diseases - therapy | Raynaud Disease - etiology | Hypertension, Pulmonary - therapy | Lung Diseases - etiology | Scleroderma, Systemic - therapy | Delphi Technique | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Raynaud Disease - therapy | Fingers | Scleroderma, Systemic - complications | Phosphodiesterase 5 Inhibitors - therapeutic use | Fluoxetine - therapeutic use | Ulcer - etiology | Ulcer - therapy | Europe | Rheumatology | Serotonin Uptake Inhibitors - therapeutic use | Hematopoietic Stem Cell Transplantation | Gastrointestinal Diseases - therapy | Prostaglandins I - therapeutic use | Pyrimidines - therapeutic use | Kidney Diseases - therapy | Kidney Diseases - etiology | Endothelin Receptor Antagonists - therapeutic use | Hypertension, Pulmonary - etiology | Endothelin | Experts | Fluoxetine | Lung diseases | Clinical trials | Stem cell transplantation | Transplantation | Prostacyclin | Patients | Literature reviews | Studies | Systemic sclerosis | Ulcers | Skin diseases | Scleroderma | Phosphodiesterase | Kidney transplantation | Rheumatology and Autoimmunity | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap | Reumatologi och inflammation
Journal Article
Journal Article
American Journal of Psychiatry, ISSN 0002-953X, 04/2009, Volume 166, Issue 4, pp. 418 - 426
Objective: The authors sought to identify predictors of self-harm adverse events in treatment-resistant, depressed adolescents during the first 12 weeks of... 
TRIALS | METAANALYSIS | INVENTORY | PSYCHIATRY | ANTIDEPRESSANT TREATMENT | RISK | TADS | SCALE | IDEATION | CHILDREN | Cyclohexanols - adverse effects | Humans | Suicide, Attempted - statistics & numerical data | Citalopram - adverse effects | Male | Paroxetine - therapeutic use | Cognitive Behavioral Therapy | Paroxetine - adverse effects | Drug Interactions | Self-Injurious Behavior - epidemiology | Suicide - psychology | Female | Fluoxetine - therapeutic use | Drug Therapy, Combination | Drug Resistance | Fluoxetine - adverse effects | Depressive Disorder, Major - drug therapy | Cross-Sectional Studies | Serotonin Uptake Inhibitors - therapeutic use | Serotonin Uptake Inhibitors - adverse effects | Suicide - statistics & numerical data | Antidepressive Agents - therapeutic use | Suicide, Attempted - psychology | Venlafaxine Hydrochloride | Self-Injurious Behavior - chemically induced | Adolescent | Cyclohexanols - therapeutic use | Citalopram - therapeutic use | Benzodiazepines - adverse effects | Antidepressive Agents - adverse effects | Benzodiazepines - therapeutic use | Cognitive therapy | Venlafaxine | Influence | Serotonin uptake inhibitors | Dosage and administration | Suicide | Drug therapy | Self-destructive behavior | Risk factors | Depression in adolescence | Methods | Depressive Disorders | Drug Abuse | SSRIs | Comorbidity | Survivors | Americans | Self Inflicted Wounds | Self Destructive Behavior | Benzodiazepines | Randomized Clinical Trial | Atypical Antidepressants | Suicidality | Predisposition | Interpersonal Interaction | Alcohol Abuse | Adolescents | Negative Therapeutic Reaction | Stressors | Index Medicus | Abridged Index Medicus
Journal Article
Acta Psychiatrica Scandinavica, ISSN 0001-690X, 02/2007, Volume 115, Issue 2, pp. 142 - 154
Journal Article